|
ATE319445T1
(de)
*
|
1997-11-24 |
2006-03-15 |
Scripps Research Inst |
HEMMER DER ßGAP JUNCTION COMMUNICATIONß
|
|
US6858649B1
(en)
*
|
1998-04-30 |
2005-02-22 |
The Scripps Research Institute |
Selective potentiation of serotonin receptor subtypes
|
|
GB9926833D0
(en)
*
|
1999-11-15 |
2000-01-12 |
Univ Sunderland |
Compositions
|
|
EP1385520A4
(en)
*
|
2001-02-08 |
2007-03-21 |
Nps Pharma Inc |
METHODS AND COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRICAL DISEASES AND FOR THE IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT THEREOF
|
|
IL158131A0
(en)
|
2001-03-27 |
2004-03-28 |
Univ California |
Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
US7351874B2
(en)
*
|
2001-07-31 |
2008-04-01 |
The Scripps Research Institute |
Mouse model for fatty acid amide-related neurobehaviors
|
|
ES2186576B1
(es)
*
|
2001-10-11 |
2004-09-16 |
Universitat De Les Illes Balears |
Acido 2-hidroxioleico para utilizar como medicamento.
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
KR20050088992A
(ko)
*
|
2002-10-07 |
2005-09-07 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
아난드아미드 가수분해 차단을 통한 불안감의 조절
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
CA2542547A1
(en)
*
|
2003-10-16 |
2005-05-26 |
Daniele Piomelli |
Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
|
|
RS56194B1
(sr)
|
2004-12-30 |
2017-11-30 |
Janssen Pharmaceutica Nv |
Derivativi fenilamida 4-(benzil)-piperazin-1-karboksilne kiseline i slična jedinjenja kao modulatori hidrolaze amida masnih kiselina (faah) za lečenje anksioznosti, bola i ostalih stanja
|
|
WO2006116773A2
(en)
*
|
2005-04-28 |
2006-11-02 |
The Regents Of The University Of California |
Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
|
|
WO2007005510A1
(en)
|
2005-06-30 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
|
|
WO2007061862A2
(en)
|
2005-11-18 |
2007-05-31 |
Janssen Pharmaceutica N.V. |
2-keto-oxazoles as modulators of fatty acid amide hydrolase
|
|
JP2009527483A
(ja)
|
2006-02-17 |
2009-07-30 |
ザ・スクリプス・リサーチ・インステイチユート |
脂肪酸アミドヒドロラーゼの調節因子としてのオキサゾールケトン
|
|
WO2007140005A2
(en)
*
|
2006-05-26 |
2007-12-06 |
Janssen Pharmaceutica N.V. |
Oxazolyl piperidine modulators of fatty acid amide hydrolase
|
|
US20080089845A1
(en)
*
|
2006-09-07 |
2008-04-17 |
N.V. Organon |
Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
CA2674359A1
(en)
*
|
2006-11-20 |
2008-05-29 |
N.V. Organon |
Metabolically-stabilized inhibitors of fatty acid amide hydrolase
|
|
CN102046179B
(zh)
*
|
2008-04-09 |
2015-01-14 |
英菲尼提制药公司 |
脂肪酸酰胺水解酶抑制剂
|
|
ES2342997B1
(es)
*
|
2008-12-09 |
2011-06-06 |
Universitat De Les Illes Balears |
Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
|
|
AU2010234449A1
(en)
|
2009-04-07 |
2011-11-03 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US8546564B2
(en)
|
2009-04-07 |
2013-10-01 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US9062116B2
(en)
|
2009-04-23 |
2015-06-23 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
JP2013518886A
(ja)
|
2010-02-03 |
2013-05-23 |
インフイニトイ プハルマセウトイカルス インコーポレイテッド |
脂肪酸アミドヒドロラーゼ阻害剤
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
EP3362462B1
(en)
|
2015-10-12 |
2021-07-21 |
Advanced Cell Diagnostics, Inc. |
In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
|
|
US12378178B2
(en)
|
2019-11-12 |
2025-08-05 |
The Trustees Of The University Of Pennsylvania |
Oleic acid derivatives as treatments for Friedreich ataxia and inhibitors of ferroptosis
|
|
CN111004125B
(zh)
*
|
2019-12-24 |
2022-11-22 |
东华理工大学 |
一种缩醛或缩酮化合物的制备方法
|
|
JP7736313B2
(ja)
|
2020-01-29 |
2025-09-09 |
ウニバシタット デ レス イレス バレアース |
αヒドロキシル化脂肪酸代謝産物、その医学的使用およびバイオマーカーとしての使用
|